407 related articles for article (PubMed ID: 28461567)
1. Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.
Saleh D; Najjar M; Zelic M; Shah S; Nogusa S; Polykratis A; Paczosa MK; Gough PJ; Bertin J; Whalen M; Fitzgerald KA; Slavov N; Pasparakis M; Balachandran S; Kelliher M; Mecsas J; Degterev A
J Immunol; 2017 Jun; 198(11):4435-4447. PubMed ID: 28461567
[TBL] [Abstract][Full Text] [Related]
2. RIPK1 inhibits ZBP1-driven necroptosis during development.
Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
[TBL] [Abstract][Full Text] [Related]
3. RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.
Najjar M; Saleh D; Zelic M; Nogusa S; Shah S; Tai A; Finger JN; Polykratis A; Gough PJ; Bertin J; Whalen M; Pasparakis M; Balachandran S; Kelliher M; Poltorak A; Degterev A
Immunity; 2016 Jul; 45(1):46-59. PubMed ID: 27396959
[TBL] [Abstract][Full Text] [Related]
4. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
6. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
[TBL] [Abstract][Full Text] [Related]
8. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Cytokine- and Influenza A Virus-Driven RIPK3 Necrosome Formation.
Thapa RJ; Nogusa S; Balachandran S
Methods Mol Biol; 2018; 1857():93-99. PubMed ID: 30136233
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles.
Ali M; Roback L; Mocarski ES
J Biol Chem; 2019 Jan; 294(3):991-1004. PubMed ID: 30504227
[TBL] [Abstract][Full Text] [Related]
11. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
12. p38
Menon MB; Gropengießer J; Fischer J; Novikova L; Deuretzbacher A; Lafera J; Schimmeck H; Czymmeck N; Ronkina N; Kotlyarov A; Aepfelbacher M; Gaestel M; Ruckdeschel K
Nat Cell Biol; 2017 Oct; 19(10):1248-1259. PubMed ID: 28920954
[TBL] [Abstract][Full Text] [Related]
13. EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.
Pearson JS; Giogha C; Mühlen S; Nachbur U; Pham CL; Zhang Y; Hildebrand JM; Oates CV; Lung TW; Ingle D; Dagley LF; Bankovacki A; Petrie EJ; Schroeder GN; Crepin VF; Frankel G; Masters SL; Vince J; Murphy JM; Sunde M; Webb AI; Silke J; Hartland EL
Nat Microbiol; 2017 Jan; 2():16258. PubMed ID: 28085133
[TBL] [Abstract][Full Text] [Related]
14. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
Wegner KW; Saleh D; Degterev A
Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
[TBL] [Abstract][Full Text] [Related]
15. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
Front Immunol; 2018; 9():1818. PubMed ID: 30154785
[TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1 enables bacterial lipids to trigger receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis and apoptosis in mice.
Meng R; Gu L; Lu Y; Zhao K; Wu J; Wang H; Han J; Tang Y; Lu B
J Biol Chem; 2019 May; 294(22):8872-8884. PubMed ID: 31000631
[TBL] [Abstract][Full Text] [Related]
17. RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection.
Downey J; Pernet E; Coulombe F; Allard B; Meunier I; Jaworska J; Qureshi S; Vinh DC; Martin JG; Joubert P; Divangahi M
PLoS Pathog; 2017 Apr; 13(4):e1006326. PubMed ID: 28410401
[TBL] [Abstract][Full Text] [Related]
18. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
[TBL] [Abstract][Full Text] [Related]
19. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
Newton K
Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
[TBL] [Abstract][Full Text] [Related]
20. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.
Peterson LW; Philip NH; DeLaney A; Wynosky-Dolfi MA; Asklof K; Gray F; Choa R; Bjanes E; Buza EL; Hu B; Dillon CP; Green DR; Berger SB; Gough PJ; Bertin J; Brodsky IE
J Exp Med; 2017 Nov; 214(11):3171-3182. PubMed ID: 28855241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
